Nasdaq-listed health-tech firm Wellgistics Health has filed an S-1 form with the SEC, detailing a comprehensive strategy to integrate the XRP Ledger (XRPL) into its payment infrastructure. The company will utilize XRP for real-time transactions across its network of 6,000+ pharmacies and 150 manufacturers, leveraging XRPL's capabilities for instant settlement at costs as low as $0.0002 per transaction—significantly faster than traditional 1-3 day bank transfers.
Wellgistics plans to raise capital through equity and debt offerings to acquire additional XRP, which will serve multiple functions: operational payments, treasury reserves, and collateral for future financing. The company also intends to generate income through staking or lending its XRP holdings. This initiative is backed by a $50 million equity line from LDA Capital.
CEO Brian Norton emphasized that XRPL adoption aims to enhance "speed, data transparency, and operational efficiency," while Ripple legal expert Bill Morgan highlighted the filing as proof of XRP's real-world utility beyond speculation. Wellgistics acknowledged regulatory risks tied to XRP's ongoing litigation but affirmed commitment to the blockchain integration.